Brokerage Nomura upheld a neutral rating on Persistent Systems, while Investec continues to advocate a buy stance on Natco Pharma and has i...

Entero has incurred losses in the past three fiscal years, raising concerns about its financial sustainability and profitability. It also f...

Entero Healthcare's IPO debuted with a discount on BSE and NSE. Proceeds will be used for debt repayment, working capital, funding subsidia...

Global private equity major Carlyle Group on Thursday sold 1.4% stake in private sector lender YES Bank for approximately Rs 1,057 crore.

In the unlisted market, the company's shares are trading with a marginal premium of Rs 2, which indicates a flat or even a discounted debut...

To check the status of Entero Healthcare Solutions allotment through the registrar, which is Bigshare Services in this case, kindly follow ...

Entero Healthcare IPO comprises a fresh equity issue of Rs 1,000 crore and an OFS of up to 47.69 lakh shares. Prabhat Agrawal, Prem Sethi, ...

Entero Healthcare IPO price band has been fixed from Rs 1,195-1258 per equity share. Bids can be made for a minimum of 11 shares and in mul...

“Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1...

Incorporated in 2018 and founded by a former chief executive of Alkem Laboratories, Mumbai-based Entero Healthcare Solutions has grown to b...

Entero Healthcare recorded a 31% YoY increase in revenue from operations during FY23, reaching Rs 3,300 crore. ICICI Securities, Dam Capita...

The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, ...

Entero Healthcare IPO: The price band has been fixed in the range of Rs 1,195-1,258 per equity share. Bids can be made for a minimum of 11 ...

Healthcare products distributors Entero Healthcare's IPO consists of a fresh issue of ₹1,000 crore and an offer for sale of 85.57 lakh shar...

These four firms, which had filed their preliminary papers with the markets watchdog between June and October, obtained observation letters...

The offer is being made through the book building process, where 75% of the issue is reserved for qualified institutional buyers, 10% for n...

Roche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...